Amoxicillin and Clarithromycin Mucoadhesive Delivery System for <i>Helicobacter pylori</i> Infection in a Mouse Model: Characterization, Pharmacokinetics, and Efficacy
<i>Helicobacter pylori</i> is the main pathogen responsible for gastric ulcers and a predisposing factor of stomach cancer. Although current treatment is usually successful, it requires high doses and frequent administration. An innovative mucoadhesive system (Mucolast<sup>®</su...
Main Authors: | Isabel Villegas, María Ángeles Rosillo, Catalina Alarcón-de-la-Lastra, Victoria Vázquez-Román, Maria Llorente, Susana Sánchez, Ana Gloria Gil, Pilar Alcalde, Esther González, Elisabet Rosell, Carles Nieto, Francisco Fernandez-Campos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/2/153 |
Similar Items
-
Effects of <i>Lactobacillus salivarius</i> LN12 in Combination with Amoxicillin and Clarithromycin on <i>Helicobacter pylori</i> Biofilm In Vitro
by: Fang Jin, et al.
Published: (2021-07-01) -
RESISTANCE TO AMOXICILLIN, CLARITHROMYCIN AND CIPROFLOXACIN OF Helicobacter pylori ISOLATED FROM SOUTHERN BRAZIL PATIENTS
by: Simone Ulrich Picoli, et al.
Published: (2014-06-01) -
Eradication efficacy of high-dose amoxicillin and proton pump inhibitor compared with quadruple therapy contained bismuth in the treatment of Helicobacter pylori
by: Eskandar Hajiani, et al.
Published: (2022-01-01) -
Novel Mutations Conferring Amoxicillin Resistance in <i>Helicobacter pylori</i> in South Korea
by: Soon Young Park, et al.
Published: (2023-04-01) -
Primary Antibiotic Resistance of <i>Helicobacter pylori</i> in Different Regions of China: A Systematic Review and Meta-Analysis
by: Jinnan Chen, et al.
Published: (2022-07-01)